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Abstract The mitochondrial import of 5-aminolevulinate
synthase (ALAS), the first enzyme of the mammalian heme
biosynthetic pathway, requires the N-terminal presequence.
The 49 amino acid presequence transit peptide (psALAS)
for murine erythroid ALAS was chemically synthesized, and
circular dichroism and 1H nuclear magnetic resonance (NMR)
spectroscopies used to determine structural elements in trifluoro-
ethanol/H2O solutions and micellar environments. A well defined
amphipathic K-helix, spanning L22 to F33, was present in
psALAS in 50% trifluoroethanol. Further, a short K-helix,
defined by A5^L8, was also apparent in the 26 amino acid
N-terminus peptide, when its structure was determined in sodium
dodecyl sulfate. Heme inhibition of ALAS mitochondrial import
has been reported to be mediated through cysteine residues in
presequence heme regulatory motifs (HRMs). A UV/visible and
1H NMR study of hemin and psALAS indicated that a heme^
peptide interaction occurs and demonstrates, for the first time,
that heme interacts with the HRMs of psALAS. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
In mammalian cells 5-aminolevulinate synthase (ALAS, EC
2.3.1.37) catalyzes the ¢rst step of the heme biosynthetic path-
way, which occurs in the mitochondrial matrix and involves
the condensation of glycine with succinyl-CoA to yield 5-ami-
nolevulinate, carbon dioxide and CoA. At least in non-ery-
throid cells, this reaction is the rate limiting step in heme
production [1^4].
In animals, two separate genes have been identi¢ed for
ALAS; one encodes the erythroid speci¢c form (ALAS2 or
ALAS-E) [5] and the other, the housekeeping gene, encodes
the hepatic form of ALAS (ALAS1 or ALAS-H) [6]. Clini-
cally, in the past few years, mutations within the human
ALAS2 gene have been identi¢ed and established to be the
basis of X-linked sideroblastic anemia [7].
ALAS is synthesized in cytosolic ribosomes as a pre-en-
zyme, which is then imported into and processed within the
mitochondria to yield the mature form of the enzyme [8^10].
Human ALAS2 is synthesized as a precursor of molecular
mass 65 kDa with an amphipathic presequence (psALAS) of
49 amino acids. During import and processing, the prese-
quence is removed to yield the mature enzyme.
Volland and Urban-Grimal [10] have shown that for yeast
ALAS the presequence was not required to target the precur-
sor protein to mitochondria; however, ALAS only reached its
¢nal destination, the mitochondrial matrix, when the prese-
quence was present. Thus, in this case, the organelle targeting
information appears to reside in the mature protein sequence
per se, whereas the subcompartmental (i.e. matrix) informa-
tion is in the presequence. It was further demonstrated that
the targeting information is encoded in non-overlapping re-
gions of the presequence [11].
In general, mitochondrial targeting presequences do not
show any sequence homology [12], although functionally, in
membrane-like environments, they all form amphipathic K-
helices that appear to be important for recognition by the
protein import machinery located in the mitochondrial mem-
brane [12,13].
High heme concentration can inhibit the mitochondrial im-
port of ALAS both in vivo and in vitro [8,9,14]. Two heme
regulatory elements, containing a single Cys residue (S10-
CPVL and R37-CPIL), were identi¢ed in the murine
ALAS2 presequence as being involved in heme inhibition of
the mitochondrial import process [15]. The deletion of heme
regulatory motifs (HRM), as well as the mutation of the Cys
to Ser residues, was found to reverse heme inhibition.
As a ¢rst step in understanding the mechanism of heme
inhibition on ALAS mitochondrial import, we have deter-
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mined the global solution structure of murine psALAS, using
circular dichroism (CD) and 1H nuclear magnetic resonance
(NMR) spectroscopy. The structure was also determined in
micellar mimetic environments. In order to identify the pres-
ence of heme binding sites in psALAS, UV/visible and NMR
titrations were conducted. The results presented here suggest
the mechanism by which heme can prevent mitochondrial im-
port of ALAS.
2. Materials and methods
2.1. Peptide synthesis and puri¢cation
The ALAS peptide H-Met-Val-Ala-Ala-Ala-Met-Leu-Leu-Arg-Ser-
Cys-Pro-Val-Leu-Ser-Gln-Gly-Pro-Thr-Gly-Leu-Leu-Gly-Lys-Val-Al-
a-Lys-Thr-Tyr-Gln-Phe-Leu-Phe-Ser-Ile-Gly-Arg-Cys-Pro-Ile-Leu-Al-
a-Thr-Gln-Gly-Pro-Thr-Cys-Ser-NH2 was synthesized using standard
Fmoc methodology on an Applied Biosystems 433A automated syn-
thesizer. TentaGel-R-RAM (Rapp Polymere, Tu«bingen, Germany)
and HBTU coupling reagent (GLS Synthesis Co., Shanghai, PR Chi-
na) were used. Each synthesis cycle incorporated double coupling of
the residues using 10-fold excess of the amino acid. The amino acids
Ser, Thr and Tyr were protected by tert-butyl, Arg by Pbf and Cys
and Gln by the Trt group. The Lys residue was Boc protected. Tem-
porary N-K-Fmoc protecting groups were removed by 20% piperidine
in N-methyl-2-pyrrolidone. The protected ALAS peptide was removed
from resin by tri£uoroacetic acid (TFA) containing 5% water, 3%
triisopropylsilane and 5% 1,2-ethanedithiol.
The crude peptide was puri¢ed by preparative HPLC using a VY-
DAC (40U300 mm) column at a £ow rate of 80 ml/min. The solvents
used were A = water containing 0.1% TFA and B = 80% acetonitrile
(0.1% TFA). The gradient was run between 47 and 97% B over 50
min. The puri¢ed peptide yielded a correct ESI mass spectrum (LCQ,
Thermoquest).
2.2. Circular dichroism
All CD measurements were made on a Jasco J720 spectropolarim-
eter at 20‡C, using a 0.1 mm path length cylindrical cell with a 1 nm
bandwidth, 0.1 nm resolution, 1 s response time and a scan speed of
100 nm/min. Each spectrum was the average of four consecutive scans
from 185 to 260 nm, followed by subtraction of the CD signal of
peptide-free solutions. The peptide concentrations varied from
30 WM to 150 WM in 2,2,2-tri£uoroethanol (TFE)/water solutions
(from 20% to 100% (v/v) in TFE) with apparent pH from 2 to 8.
TFE was obtained from Sigma (99+%; T6, 300-2).
2.3. UV/visible absorption spectroscopy
Hemin (Porphyrin Products, UT, USA) was solubilized in a 2 M
NaOH solution, and a SDS/phosphate bu¡er solution was added to
give ¢nal concentrations of 1 mM hemin, 1.5 mM SDS and 10 mM
phosphate. The pH was adjusted to 5.4.
Hemin^peptide titrations were followed by UV/visible absorption
spectroscopy. Measurements were made on a UNICAM UV2 spec-
trometer. The spectra were acquired between 300 nm and 750 nm. The
hemin solution was dissolved in a 50% TFE/water solution to give a
¢nal concentration of 20 WM, which was titrated with the peptide.
2.4. NMR spectroscopy
2.4.1. Sample preparation. The samples for NMR contained 2^3
mg of peptide dissolved in 500 Wl of a 1:1 solution of deionized H2O/
TFE-d2 (Euriso-top, France). The solvents had been previously
bubbled with nitrogen to remove any oxygen present. The pH of
each solution was adjusted to ca. 3 (uncorrected meter reading)
with dilute (0.1 M) HCl. The preparation of the peptide samples in
SDS micelles was based on the method of Killian et al. [16]. Equal
volumes of a solution consisting of 2^3 mg of the peptide in TFE and
a solution of SDS-d25 were vortexed. The sample was then diluted
with deionized water to a ¢nal volume of 3 ml and vortexed and
lyophilized. The resulting solid was resuspended in 500 Wl of H2O,
pH 3, giving a ¢nal SDS concentration of 100 mM.
2.4.2. Spectra acquisition. All NMR spectra were recorded on a
Bruker DMX600 spectrometer at 300 K. The 2D total correlation
spectroscopy (TOCSY) spectra were recorded using a ‘clean’ TOCSY
[17] sequence with a 100 ms mixing time. The 2D nuclear Overhauser
e¡ect spectroscopy (NOESY) [18] spectra were recorded with a 150 ms
mixing time. The TOCSY and NOESY spectra were recorded with
2048U800 data points, multiplied by a shifted sine-squared window
and zero ¢lled to a ¢nal size of 2kU2k. The 2D double quantum
¢ltered correlated spectroscopy (DQF-COSY) spectra [19] were re-
corded with 4096U1024 data points, multiplied by a shifted sine-
squared window and zero ¢lled to a ¢nal size of 8kU2k.
Spectral processing was carried out using NMRPipe [20], and peak
picking, assignment and integration were carried out using SPARKY
[21]. The calculation of the solution structures was carried out using
DYANA [22] and the manipulation of the structures using MOLMOL
[23].
3. Results
3.1. CD experiments
The psALAS peptide was found to be insoluble in 100%
water; a mixture of TFE/H2O was used to dissolve the pep-
tide. CD titrations of a TFE solution of the peptide with
water were performed; they showed that the peptide adopts
an K-helical conformation (minima at 206 and 222 nm). The
minimum TFE percentage for which the peptide presented an
K-helix conformation was found to be 50%. Subsequently the
behavior of the 50% TFE solution, corresponding to mini-
mum TFE content and maximal helical structure, was moni-
tored with respect to pH (2^5.8) and the peptide concentra-
tion (10^150 WM) in order to determine the best experimental
conditions for the NMR experiments. The invariance of the
CD spectra under all these conditions implied the peptide
remained fully dissolved in solution and showed a relatively
wide window under which NMR measurements could be per-
formed.
3.2. NMR experiments
A combination of the DQF-COSY and 110 ms TOCSY
spectra in 50% H2O/50% TFE was used to identify the full
set of 49 spin systems for psALAS in the TOCSY spectrum. A
number of extra, weak spin systems were identi¢ed and cor-
respond to systems containing cis-proline moieties. The low
intensity of these addition signals is compatible with the ab-
sence of aromatic moieties adjacent to the proline residues
and con¢rms that the major signals correspond to the all
trans-proline system [24]. The sequence speci¢c assignment
Fig. 1. The chemical shift deviations from random coil values [25]
for the HK resonances of psALAS. An K-helix is indicated, by the
sequence of consecutive shift di¡erences greater than 30.1 ppm, for
A4^L8 and for L22^S34.
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of the major spin systems was then determined through in-
spection of the 150 ms NOESY spectrum.
The identi¢cation of secondary structural elements in ps-
ALAS was carried out using a qualitative assessment of the
NOE pattern and the HK chemical shift data. Fig. 1 shows
the deviation of the HK chemical shifts from their random coil
values for each residue [25]. Using the medium range NOEs,
HK^HN(i,i33) and HK^HL(i,i+3), observed in the 150 ms
NOESY spectrum (supplementary information), an K-helix
was identi¢ed spanning residues L22 to F33 and is supported
by the observation of strong NH-NH(i,i+1) NOEs and the
HK chemical shift data. There are no other obvious regions
of structure for the N-terminal region of the peptide from the
NOE data, although the HK chemical shifts data suggests a
possible short K-helix for the section A4^R9.
The intensities of the NOESY cross peaks were converted
into distance constraints using the CALIBA module of the
program DYANA in which a cut-o¡ distance of 6.0 Aî was
used.
From the integration and calibration of the 386 assigned
cross-peaks in the 150 ms NOESY spectrum (corresponding
to 58 intra-residue, 77 sequential and 37 medium range
Fig. 2. A: The low TF family of 30 structures of psALAS. The backbone atoms are shown and superposition of the section L22^F33 has been
carried out. B: Ribbon diagram showing the secondary structural elements for the structure closest to the mean structure from NMR (calcu-
lated by MOLMOL [23]).
Fig. 3. The chemical shift deviations from random coil values [25]
for the HK resonances of N-psALAS. A short K-helix is indicated
by the sequence of six consecutive shift di¡erences greater than
30.1 ppm from A4 to R9.
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NOEs), 172 upper distance limits were obtained. Using these
upper limits, 49 lower limits and 20 P/i angle constraints from
JNHÿHK coupling constants, the torsion angle dynamics pro-
gram DYANA gave a NMR family of 30 structures (protein
databank code 1h7d) with target functions (TF) less than
1.15U1032 Aî 2 (average TF 5.8U1032 þ 3.7U1033 Aî 2), and
with no distance or angle violations. The root mean square
deviations (rmsd) between the members of the family and
between the mean structure for the backbone atoms for all
49 residues and for residues 22^33 (well de¢ned helix) were
8.30 þ 1.84 Aî and 0.67 þ 0.24 Aî respectively. A stereoview
superposition of these 30 best constrained structures deter-
mined from the NMR data after alignment of the G23^F33
K-helix is shown in Fig. 2A, together with a ribbon diagram of
the secondary structure elements in the closest structure to the
mean NMR structure (calculated by MOLMOL [23]) in Fig.
2B. In order to determine the regions with the lowest rmsd for
¢tting, consecutive segments (of length one to four residues)
of the peptide were compared using a program based on
Blankenfeldt et al. [26]. It was found that the region L22^
F33 displayed the lowest rmsd (6 0.75 Aî ) coinciding with
the well de¢ned K-helix. No other regular structure was read-
ily detectable in any of the ¢nal structures. The HK chemical
shift data are in agreement with the observed K-helix. The
same data also show six consecutive shift di¡erences greater
than 30.1 ppm from A4 to R9 that suggest the presence of a
short K-helix, although no medium range NOEs were ob-
served in the NOESY spectrum.
In order to probe the structure of the N-terminus in more
detail the 26 amino acid N-terminal fragment of psALAS (N-
psALAS) was synthesized and NMR spectra were recorded in
50% TFE. To observe the e¡ect of a more hydrophobic envi-
ronment on the structure, spectra were also recorded in SDS
micelles. The HK chemical shift data are shown in Fig. 3. In
50% TFE there appears to be very little regular secondary
structure from the qualitative NOE data, although again the
HK chemical shift data indicate a short helical region for A4^
R9. In SDS, however, the presence of i,i+2 and i,i+3 NOEs in
the region V2^L7 (2^4, 3^5, 5^7 HK^HN; 4^6, 5^7 HN^HN;
3^6 HK^HN), and the HK chemical shift data con¢rm a sta-
bler structure under these conditions (supplementary informa-
tion). A family of 15 structures were calculated for N-psALAS
in SDS using NOE data from the 150 ms NOESY spectrum
(49 intra-residue, 54 sequential and 26 medium range NOEs
giving a total of 129 upper distance limits). The torsion angle
dynamics program DYANA gave structures with TFs less
than 1.6U1032 Aî 2 (average TF 1.2U1032 þ 4.5U1033 Aî 2).
A ¢tting based on Blankenfeldt et al. [26] was carried out
with the lowest rmsd (6 0.75 Aî ) coinciding with the region
Fig. 4. Stereoview of the low TF family of 15 structures of N-psALAS. The backbone atoms are shown and superposition of the section A4^
L8 has been carried out.
Fig. 5. Absorption spectra of hemin/psALAS titration, showing the
characteristic hemin Soret band at 388 nm, decreasing in intensity
on psALAS addition. A new band at 371 nm appears due to the
hemin/psALAS interaction. The inset shows the variation of the in-
tensity at 370 nm as a function of the hemin/psALAS molar ratio,
indicating that an interaction is taking place with a stoichiometry of
approximately 2:1. This stoichiometry is consistent with two hemin
molecules interacting with the two HRMs present in one psALAS
molecule.
Fig. 6. Low ¢eld region of 1D 1H NMR spectra of (a) hemin solu-
tion, pH 5 and (b) psALAS 50% TFE, pH 5 after addition of 25%
equivalent of hemin.
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A4^L8. An analysis of the structures in the family (protein
databank code 1h7j) showed that this region is mainly K-hel-
ical (Fig. 4). Although only four of the 15 have ‘classic’ K-
helical structure, the Ramachandran plot of the NMR family
indicates that the residues A4^L8 all fall within core or al-
lowed K-helix regions of the plot.
3.3. Heme interactions
The presence of heme is known to inhibit the import of
ALAS into mitochondria [8,14,15]. Therefore, in order to ad-
dress, at a structural level, the mechanism of inhibition, UV/
visible titrations were initially used to study the psALAS/heme
interaction. Using the characteristic heme absorption spec-
trum [27], a hemin solution was titrated with the psALAS
peptide. The Soret band, with a maximum at 388 nm, shifted
to a shorter wavelength of 370 nm on addition of psALAS
(Fig. 5), indicating that an interaction is taking place. The
change in absorbance at 370 nm plotted as a function of the
molar ratio (psALAS/hemin) shows a 1:2 relationship (Fig. 5,
inset). This stoichiometry is consistent with two hemin mole-
cules interacting with the two HRMs present in one psALAS
molecule. A titration of hemin with N-psALAS presented
similar shifts in the Soret band (to 370 nm), although here
the stoichiometry was 1:1, due to the presence of only one of
the HRMs in the smaller N-psALAS peptide.
The hemin/psALAS interaction was also probed by 1H
NMR spectroscopy. The presence of a high spin Fe3 atom
(S = 5/2) induces paramagnetic shifts in the protons of the
porphyrin ring, due to transfer of spin density from the
Fe atom. A comparison between a hemin solution and a ps-
ALAS^hemin mixture indicated that there were clear di¡er-
ences in the low ¢eld region of the 1D proton spectra for these
resonances (Fig. 6). If heme^psALAS interactions are present,
shifts for the hyper¢ne shifted hemin resonances would be
expected, due to a change in the distribution of the electron
spin density resulting from the interaction. Also, the fact that
the resonances are broader than those for the free hemin may
indicate equilibrium between the free hemin and the hemin/
peptide complex. The observed low ¢eld shift of the porphyrin
resonances in the presence of psALAS is also consistent with a
change in coordination number for the Fe. A NMR study of
Fe(III) protoporphyrin IX [28] showed the methyl resonances
appearing down¢eld at 50^55 ppm when no axial ligands are
present. When the Fe was 5- or 6-coordinate the methyl res-
onances shifted to 55^65 ppm. Thus the shifts observed on the
introduction of psALAS to hemin are consistent with axial
coordination of the Fe atom. Electron paramagnetic reso-
nance spectra were also obtained for the hemin and hemin/
peptide samples (data not shown), presenting characteristic
gW6 features indicative of the presence of a high spin Fe3
[29]. The di¡erences in g features seen by peptide addition can
be attributed to a change in axial coordination, namely, a
water molecule that has been replaced by an interacting ligand
which maintains the weak ligand ¢eld. Interaction of the sul-
fur atom of a cysteine residue would maintain this weak ¢eld.
4. Discussion
The widely accepted import process by which ALAS (or
any mitochondrial protein) is transported into the mitochon-
dria includes many steps [12], one of the most important being
the initial recognition step involving the N-terminal prese-
quence. Translocase of the outer membrane (TOM) and trans-
locase of the inner membrane (TIM) protein complexes ap-
pear responsible for recognition and import through the
mitochondrial membrane [12]. The protein Tom20 is anchored
to the mitochondrial outer membrane, and its interaction with
presequences is thought to be the recognition step which al-
lows subsequent import. A number of studies have shown that
an amphipathic N-terminal K-helix is a requirement for mito-
chondrial presequences and that positive charges, present at
the N-terminal in almost all known presequences, are also
essential [12]. A recent NMR study of a complex between
rat Tom20 and a 10 amino acid presequence from the C-ter-
minus of the aldehyde dehydrogenase presequence [30]
showed that a hydrophobic patch on the Tom20 protein is
used to recognize presequences, the hydrophobic region of the
presequence interacting with this patch and the hydrophilic
region interacting with solvent or negatively charged side
chains from Tom20. Mutation studies suggested that prese-
quence interaction with Tom20 occurs via hydrophobic inter-
actions and that the presence of positive charges in the prese-
quence is non-essential for recognition [30]. The positive
charges are, therefore, thought to be required further along
the recognition import chain.
Fig. 7. Surface representation showing the charge distribution
(black = positive) for the amphipathic K-helix at (A) L22^F33 and
(B) A4^R9 for the closest structure to the mean NMR structure for
psALAS and N-psALAS respectively.
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A recent study of the interaction of the presequence peptide
of mitochondrial aspartate aminotransferase with model
membranes [31] suggested that the N-terminal portion of the
29 amino acid presequence mediates binding to the mem-
brane. It was also suggested, using secondary structure pre-
diction methods, that a second amphipathic helical segment is
present and that this helix may be the Tom20 recognition
element for mitochondrial import.
Our present study has shown that, in 50% TFE, the 49
amino acid psALAS exists as an amphipathic helix, at L22^
F33, with a positively charged surface provided by two lysine
residues (Fig. 7A) and no stable helix at the N-terminus. The
results for the shorter 26 amino acid N-terminal N-psALAS
(which contains eight hydrophobic residues, followed by an
arginine) also indicate a lack of stable structure in 50% TFE.
However, in the more hydrophobic environment of micelles a
short helix is formed. Fig. 7B shows an electrostatic surface
for the mean NMR structure of N-psALAS in SDS, where it
can be seen that the short helix is amphipathic, the hydro-
phobic side involving three alanines and two leucines and the
hydrophilic side a positive arginine residue. It appears, there-
fore, that psALAS has the characteristics common to all mi-
tochondrial presequences: positively charged residues, a pro-
pensity to form an amphipathic N-terminal K-helix in
membrane-like hydrophobic environments, and a second hel-
ical structural element.
High heme concentrations inhibit the translocation of the
ALAS precursor into mitochondria [8,14,15]; thus conceiv-
ably, heme could control not only the ALAS mitochondrial
import but also the heme biosynthetic pathway. The results
from the present heme^peptide interaction studies demon-
strate that heme interacts at a 2:1 ratio with psALAS and
at a 1:1 ratio with N-psALAS and the ligand that interacts
does so maintaining a weak ligand ¢eld at the Fe. These
results combined with the recognition that there are two
HRMs in psALAS and that both contain Cys (S when bound
to Fe will maintain a weak ¢eld) suggest that heme is inter-
acting with the Cys in the HRM. The shifts seen in the UV/
visible titrations are also very similar to those seen (388^362
nm) for titrations of hemin with a peptide containing the
HRM of HAP1 where cysteine binding also occurs [27].
Fig. A1. Summary of sequential and medium range NOE connectivities observed for psALAS in 50% TFE. The intensities of sequential NOEs
are categorized as strong, medium and weak and are represented by the thickness of the lines.
Fig. A2. Summary of sequential and medium range NOE connectiv-
ities observed for N-psALAS in 50% TFE and SDS. The intensities
of sequential NOEs are categorized as strong, medium and weak
and are represented by the thickness of the lines.
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Structurally, the ¢rst HRM is very close to the N-terminal
helix, with the side chain of C11 directed toward the hydro-
phobic side of this helix. If heme interacts at this site, the
initial recognition between the membrane and the N-terminal
helix would be a¡ected due to changes in the charge/hydro-
phobicity induced by the presence of heme and hence anchor-
age of the presequence in the membrane would be more di⁄-
cult. The same argument can be applied to the second HRM
which follows the well de¢ned helix at L22^F33. In this case
interference with the interaction of this region with the hydro-
phobic patch on the import receptor of Tom20 would be more
di⁄cult. Thus in this model the heme interaction prevents or
severely modi¢es those areas of the peptide with a propensity
for helical formation coming into contact both with the mem-
brane and with the hydrophobic regions of the receptor(s),
most probably through disruption of the hydrophobic envi-
ronment necessary for helix formation of the presequence.
Hence our results are consistent with an interaction model
involving two recognition elements: the short N-terminal hy-
drophobic region, which becomes structured in the presence
of membrane mimetic environments, and a longer well de¢ned
K-helix which can interact with a hydrophobic patch on
Tom20 or another import receptor.
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